Skip to content

The evaluation of a program to promote self management and quality of life of kidney patients (STERK-program)

The evaluation of a program to promote self management and quality of life of kidney patients (STERK-program) - Self management and quality of life of patients with chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35186
Enrollment
170
Registered
2011-12-07
Start date
2012-02-19
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease kidney failure

Interventions

The intervention consists of four meetings lasting two hours in an eighty to twelve weeks period and a meeting three months afterwards. The meetings are interactive and consist of what it is like to

Sponsors

Nierstichting Nederland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed patients Patients with progressive chronic kidney disease 18 years of age and older

Exclusion criteria

Exclusion criteria: Non-Dutch spreaking Not allowed to give informed consent Mental or cognitive problems Not able to participate in groups

Design outcomes

Primary

MeasureTime frame
The primary outcomes of the process evaluation is primarily aimed at the workability and the feasibility of the STERK program. The content and the structure of the training will be evaluated at the level of the patient and the professional. The effect evaluation will focus on the extent in which the training affects self management abilities, perceptions of illness and treatment, self efficacy, proactive competences and quality of life of patients.

Secondary

MeasureTime frame
The secundary outcomes of the study are glomerular filtration rate (GFR), proteinuria blood pressure, Body Mass Index, salt intake, protein intake.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)